Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy

IPAC Investigators

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The etiology of peripartum cardiomyopathy remains unknown. One hypothesis is that an increase in the 16-kDa form of prolactin is pathogenic and suggests that breastfeeding may worsen peripartum cardiomyopathy by increasing prolactin, while bromocriptine, which blocks prolactin release, may be therapeutic. An autoimmune etiology has also been proposed. The authors investigated the impact of breastfeeding on cellular immunity and myocardial recovery for women with peripartum cardiomyopathy in the IPAC (Investigations in Pregnancy Associated Cardiomyopathy) study. Women who breastfed had elevated prolactin, and prolactin levels correlated with elevations in CD8+ T cells. However, despite elevated prolactin and cytotoxic T cell subsets, myocardial recovery was not impaired in breastfeeding women.

Original languageEnglish (US)
Pages (from-to)291-300
Number of pages10
JournalJACC: Basic to Translational Science
Volume4
Issue number3
DOIs
StatePublished - Jun 1 2019

Fingerprint

Peripartum Period
Breast Feeding
Cardiomyopathies
Prolactin
Bromocriptine
T-Lymphocyte Subsets
Cellular Immunity
T-Lymphocytes
Pregnancy

Keywords

  • breastfeeding
  • immune activation
  • peripartum cardiomyopathy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy. / IPAC Investigators.

In: JACC: Basic to Translational Science, Vol. 4, No. 3, 01.06.2019, p. 291-300.

Research output: Contribution to journalArticle

@article{3478dc2a83c640b596b20da2554a3b50,
title = "Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy",
abstract = "The etiology of peripartum cardiomyopathy remains unknown. One hypothesis is that an increase in the 16-kDa form of prolactin is pathogenic and suggests that breastfeeding may worsen peripartum cardiomyopathy by increasing prolactin, while bromocriptine, which blocks prolactin release, may be therapeutic. An autoimmune etiology has also been proposed. The authors investigated the impact of breastfeeding on cellular immunity and myocardial recovery for women with peripartum cardiomyopathy in the IPAC (Investigations in Pregnancy Associated Cardiomyopathy) study. Women who breastfed had elevated prolactin, and prolactin levels correlated with elevations in CD8+ T cells. However, despite elevated prolactin and cytotoxic T cell subsets, myocardial recovery was not impaired in breastfeeding women.",
keywords = "breastfeeding, immune activation, peripartum cardiomyopathy",
author = "{IPAC Investigators} and Agnes Koczo and Amy Marino and Arun Jeyabalan and Uri Elkayam and Cooper, {Leslie T Jr.} and James Fett and Joan Briller and Eileen Hsich and Lori Blauwet and Charles McTiernan and Morel, {Penelope A.} and Karen Hanley-Yanez and McNamara, {Dennis M.} and McNamara, {Dennis M.} and Fett, {James D.} and Jessica Pisarcik and John Gorcsan and Erik Schelbert and Rami Alharethi and Kismet Rasmusson and Kim Brunisholz and Amy Butler and Deborah Budge and Kfoury, {A. G.} and Benjamin Horne and Joe Tuinei and Heather Brown and Julie Damp and Naftilan, {Allen J.} and Jill Russell and Darla Freehardt and Cynthia Oblak and Greg Ewald and Donna Whitehead and Jean Flanagan and Anne Platts and Jorge Caro and Stephanie Mullin and Givertz, {Michael M.} and Anello, {M. Susan} and Navin Rajagopalan and David Booth and Tiffany Sandlin and Wendy Wijesiri and Blauwet, {Lori A.} and Joann Brunner and Mary Phelps and Ruth Kempf and Kalgi Modi and Tracy Norwood",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.jacbts.2019.01.010",
language = "English (US)",
volume = "4",
pages = "291--300",
journal = "JACC: Basic to Translational Science",
issn = "2452-302X",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy

AU - IPAC Investigators

AU - Koczo, Agnes

AU - Marino, Amy

AU - Jeyabalan, Arun

AU - Elkayam, Uri

AU - Cooper, Leslie T Jr.

AU - Fett, James

AU - Briller, Joan

AU - Hsich, Eileen

AU - Blauwet, Lori

AU - McTiernan, Charles

AU - Morel, Penelope A.

AU - Hanley-Yanez, Karen

AU - McNamara, Dennis M.

AU - McNamara, Dennis M.

AU - Fett, James D.

AU - Pisarcik, Jessica

AU - Gorcsan, John

AU - Schelbert, Erik

AU - Alharethi, Rami

AU - Rasmusson, Kismet

AU - Brunisholz, Kim

AU - Butler, Amy

AU - Budge, Deborah

AU - Kfoury, A. G.

AU - Horne, Benjamin

AU - Tuinei, Joe

AU - Brown, Heather

AU - Damp, Julie

AU - Naftilan, Allen J.

AU - Russell, Jill

AU - Freehardt, Darla

AU - Oblak, Cynthia

AU - Ewald, Greg

AU - Whitehead, Donna

AU - Flanagan, Jean

AU - Platts, Anne

AU - Caro, Jorge

AU - Mullin, Stephanie

AU - Givertz, Michael M.

AU - Anello, M. Susan

AU - Rajagopalan, Navin

AU - Booth, David

AU - Sandlin, Tiffany

AU - Wijesiri, Wendy

AU - Blauwet, Lori A.

AU - Brunner, Joann

AU - Phelps, Mary

AU - Kempf, Ruth

AU - Modi, Kalgi

AU - Norwood, Tracy

PY - 2019/6/1

Y1 - 2019/6/1

N2 - The etiology of peripartum cardiomyopathy remains unknown. One hypothesis is that an increase in the 16-kDa form of prolactin is pathogenic and suggests that breastfeeding may worsen peripartum cardiomyopathy by increasing prolactin, while bromocriptine, which blocks prolactin release, may be therapeutic. An autoimmune etiology has also been proposed. The authors investigated the impact of breastfeeding on cellular immunity and myocardial recovery for women with peripartum cardiomyopathy in the IPAC (Investigations in Pregnancy Associated Cardiomyopathy) study. Women who breastfed had elevated prolactin, and prolactin levels correlated with elevations in CD8+ T cells. However, despite elevated prolactin and cytotoxic T cell subsets, myocardial recovery was not impaired in breastfeeding women.

AB - The etiology of peripartum cardiomyopathy remains unknown. One hypothesis is that an increase in the 16-kDa form of prolactin is pathogenic and suggests that breastfeeding may worsen peripartum cardiomyopathy by increasing prolactin, while bromocriptine, which blocks prolactin release, may be therapeutic. An autoimmune etiology has also been proposed. The authors investigated the impact of breastfeeding on cellular immunity and myocardial recovery for women with peripartum cardiomyopathy in the IPAC (Investigations in Pregnancy Associated Cardiomyopathy) study. Women who breastfed had elevated prolactin, and prolactin levels correlated with elevations in CD8+ T cells. However, despite elevated prolactin and cytotoxic T cell subsets, myocardial recovery was not impaired in breastfeeding women.

KW - breastfeeding

KW - immune activation

KW - peripartum cardiomyopathy

UR - http://www.scopus.com/inward/record.url?scp=85067245048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067245048&partnerID=8YFLogxK

U2 - 10.1016/j.jacbts.2019.01.010

DO - 10.1016/j.jacbts.2019.01.010

M3 - Article

VL - 4

SP - 291

EP - 300

JO - JACC: Basic to Translational Science

JF - JACC: Basic to Translational Science

SN - 2452-302X

IS - 3

ER -